ABSTRACT
Outside pregnancy, acute caffeine consumption is associated with insulin resistance.
We investigated if during pregnancy plasma concentrations of caffeine and its metabolite,
paraxanthine, were associated with insulin resistance. Caffeine, paraxanthine, glucose,
and insulin were measured and insulin resistance estimated by homeostasis model assessment
(HOMA) in banked samples from 251 fasting subjects at mean gestational age of 20.3 ± 2.0
weeks. Analysis of covariance and adjusted logistic regression were performed. Most
(96.4%) women had caffeine and/or paraxanthine present. Caffeine concentrations in
the upper two quartiles (>266 ng/mL) were associated with threefold higher odds of
having higher insulin resistance estimated by log HOMA ≥75th percentile (third quartile
odds ratio [OR], 3.02; 95% confidence interval [CI]: 1.21 to 7.54 and fourth quartile
OR, 2.95; 95% CI: 1.19 to 7.31). Paraxanthine concentrations in the upper quartile
(>392 ng/mL) were also associated with threefold higher odds of having higher insulin
resistance (OR, 3.04; 95% CI: 1.28 to 7.25). Adjusted mean HOMA in the first caffeine-to-paraxanthine
ratio quartile was 1.5 ± 2.2 versus 1.3 ± 2.3 in the fourth quartile (p < 0.01). Both high caffeine and paraxanthine concentrations were associated with
insulin resistance, but slow versus fast metabolism did not make an important difference.
KEYWORDS
Caffeine - insulin resistance - paraxanthine
REFERENCES
- 1
Frary C D, Johnson R K, Wang M Q.
Food sources and intakes of caffeine in the diets of persons in the United States.
J Am Diet Assoc.
2005;
105
110-113
- 2
Eskenazi B.
Caffeine—filtering the facts.
N Engl J Med.
1999;
341
1688-1689
- 3
Robinson L E, Savani S, Battram D S, McLaren D H, Sathasivam P, Graham T E.
Caffeine ingestion before an oral glucose tolerance test impairs blood glucose management
in men with type 2 diabetes.
J Nutr.
2004;
134
2528-2533
- 4
Petrie H J, Chown S E, Belfie L M et al..
Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test
in obese men before and after weight loss.
Am J Clin Nutr.
2004;
80
22-28
- 5
Keijzers G B, De Galan B E, Tack C J, Smits P.
Caffeine can decrease insulin sensitivity in humans.
Diabetes Care.
2002;
25
364-369
- 6
Lane J D, Barkauskas C E, Surwit R S, Feinglos M N.
Caffeine impairs glucose metabolism in type 2 diabetes.
Diabetes Care.
2004;
27
2047-2048
- 7
Pizziol A, Tikhonoff V, Paleari C D et al..
Effects of caffeine on glucose tolerance: a placebo-controlled study.
Eur J Clin Nutr.
1998;
52
846-849
- 8
Thong F S, Graham T E.
Caffeine-induced impairment of glucose tolerance is abolished by beta-adrenergic receptor
blockade in humans.
J Appl Physiol.
2002;
92
2347-2352
- 9
Thong F S, Derave W, Kiens B et al..
Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal
muscle is reduced by exercise.
Diabetes.
2002;
51
583-590
- 10
Avogaro A, Toffolo G, Valerio A, Cobelli C.
Epinephrine exerts opposite effects on peripheral glucose disposal and glucose-stimulated
insulin secretion. A stable label intravenous glucose tolerance test minimal model
study.
Diabetes.
1996;
45
1373-1378
- 11
Lane J D.
Caffeine may raise insulin resistance in prediabetics.
ObGynNews.
2007;
(June 1)
36
- 12
van Dam R M, Hu F B.
Coffee consumption and risk of type 2 diabetes: a systematic review.
JAMA.
2005;
294
97-104
- 13
Wolf M, Sandler L, Jimenez-Kimble R, Shah A, Ecker J L, Thadhani R.
Insulin resistance but not inflammation is associated with gestational hypertension.
Hypertension.
2002;
40
886-891
- 14
Wolf M, Sandler L, Muñoz K, Hsu K, Ecker J L, Thadhani R.
First trimester insulin resistance and subsequent preeclampsia: a prospective study.
J Clin Endocrinol Metab.
2002;
87
1563-1568
- 15
Hadden D R.
Prediabetes and the big baby.
Diabet Med.
2008;
25
1-10
- 16
Robinson L E, Spafford C, Graham T E, Smith G N.
Acute caffeine ingestion and glucose tolerance in women with or without gestational
diabetes mellitus.
J Obstet Gynaecol Can.
2009;
31
304-312
- 17
Adeney K L, Williams M A, Schiff M A, Qiu C, Sorensen T K.
Coffee consumption and the risk of gestational diabetes mellitus.
Acta Obstet Gynecol Scand.
2007;
86
161-166
- 18 Daly J. Caffeine, coffee and health. In: Garattini S, ed. Mechanism of Action of
Caffeine. New York: Raven Press; 1993: 97-149
- 19
Grosso L M, Bracken M B.
Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment
considerations during pregnancy.
Ann Epidemiol.
2005;
15
460-466
- 20
Grosso L M, Triche E W, Belanger K, Benowitz N L, Holford T R, Bracken M B.
Caffeine metabolites in umbilical cord blood, cytochrome P-450 1A2 activity, and intrauterine
growth restriction.
Am J Epidemiol.
2006;
163
1035-1041
- 21
Carpenter M W, Coustan D R.
Criteria for screening tests for gestational diabetes.
Am J Obstet Gynecol.
1982;
144
768-773
- 22
Dooley S L, Metzger B E, Cho N, Liu K.
The influence of demographic and phenotypic heterogeneity on the prevalence of gestational
diabetes mellitus.
Int J Gynaecol Obstet.
1991;
35
13-18
- 23
Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C.
Homeostasis model assessment: insulin resistance and beta-cell function from fasting
plasma glucose and insulin concentrations in man.
Diabetologia.
1985;
28
412-419
- 24
Cohen O, Epstein G S, Weisz B, Homko C J, Sivan E.
Longitudinal assessment of insulin sensitivity in pregnancy. Validation of the homeostasis
model assessment.
Clin Endocrinol (Oxf).
2006;
64
640-644
- 25
Holland D T, Godfredsen K A, Page T, Connor J D.
Simple high-performance liquid chromatography method for the simultaneous determination
of serum caffeine and paraxanthine following rapid sample preparation.
J Chromatogr B Biomed Sci Appl.
1998;
707
105-110
- 26
Jeyabalan A, Powers R W, Durica A R, Harger G F, Roberts J M, Ness R B.
Cigarette smoke exposure and angiogenic factors in pregnancy and preeclampsia.
Am J Hypertens.
2008;
21
943-947
- 27
Metzger B E, Lowe L P, Dyer A R HAPO Study Cooperative Research Group et al.
Hyperglycemia and adverse pregnancy outcomes.
N Engl J Med.
2008;
358
1991-2002
- 28
Graham T E, Sathasivam P, Rowland M, Marko N, Greer F, Battram D.
Caffeine ingestion elevates plasma insulin response in humans during an oral glucose
tolerance test.
Can J Physiol Pharmacol.
2001;
79
559-565
- 29
Shi C L.
Effects of caffeine and acetylcholine on glucose-stimulated insulin release from islet
transplants in mice.
Cell Transplant.
1997;
6
33-37
- 30
Bruton J D, Lemmens R, Shi C L et al..
Ryanodine receptors of pancreatic beta-cells mediate a distinct context-dependent
signal for insulin secretion.
FASEB J.
2003;
17
301-303
- 31
Parsons W D, Neims A H.
Effect of smoking on caffeine clearance.
Clin Pharmacol Ther.
1978;
24
40-45
- 32
Kalow W, Tang B K.
Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette
smoking.
Clin Pharmacol Ther.
1991;
49
44-48
- 33
Benowitz N L.
Clinical pharmacology of caffeine.
Annu Rev Med.
1990;
41
277-288
- 34
Hedley A A, Ogden C L, Johnson C L, Carroll M D, Curtin L R, Flegal K M.
Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002.
JAMA.
2004;
291
2847-2850
S. Katherine LaughonM.D. M.S.
IRTA Postdoctoral Fellow, Division of Epidemiology, Statistics and Prevention Research,
Eunice Kennedy Shriver National Institute of Child Health and Human Development
6100 Executive Blvd., Room 7B03, Rockville, MD 20852
Email: laughonsk@mail.nih.gov